Y Mabs Therapeutics Stock Investor Sentiment

YMAB Stock  USD 6.16  0.02  0.32%   
About 69% of Y MAbs' investor base is looking to short. The analysis of the overall investor sentiment regarding Y mAbs Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Y MAbs' historical and current headlines, can help investors time the market. In addition, many technical investors use Y mAbs Therapeutics stock news signals to limit their universe of possible portfolio assets.
  

Y MAbs Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Y MAbs can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over six months ago at investing.com         
BMO sees 40 percent upside on Y-mAbs shares, cites efficient cost structure
Investing News at Macroaxis
over six months ago at insidermonkey.com         
Y-mAbs Therapeutics, Inc. Q4 2023 Earnings Call Transcript
insidermonkey News
over six months ago at finance.yahoo.com         
Y-mAbs Therapeutics, Inc. Q4 2023 Earnings Call Transcript
Yahoo News
over six months ago at finance.yahoo.com         
Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors
Yahoo News
over six months ago at finance.yahoo.com         
Y-mAbs Therapeutics Full Year 2023 Earnings Beats Expectations
Yahoo News
over six months ago at marketwatch.com         
Y-mAbs Therapeutics Shares Rise 20 percent After Narrower-Than-Expected 4Q Loss
marketwatch News
over six months ago at finance.yahoo.com         
Y-mAbs Therapeutics Inc Reports Strong Revenue Growth in Q4 and Full Year 2023
Yahoo News
over six months ago at seekingalpha.com         
Insider Trading
seekingalpha News
over six months ago at zacks.com         
Y-mAbs Therapeutics, Inc. Reports Q4 Loss, Tops Revenue Estimates
zacks News
over six months ago at finance.yahoo.com         
Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments
Yahoo News
over six months ago at seekingalpha.com         
Y-mAbs up 17 percent after hours on strong 2024 guidance, quarterly beats
seekingalpha News
over six months ago at gurufocus.com         
Y-mAbs Therapeutics Inc Reports Strong Revenue Growth in Q4 and Full Year 2023
Gurufocus Stories at Macroaxis
over six months ago at thelincolnianonline.com         
Y-mAbs Therapeutics Set to Announce Quarterly Earnings on Thursday
news
over six months ago at news.google.com         
Y-mAbs Therapeutics, Inc. Shares Purchased by Acadian Asset Management LLC - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Y MAbs that are available to investors today. That information is available publicly through YMAB media outlets and privately through word of mouth or via YMAB internal channels. However, regardless of the origin, that massive amount of YMAB data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Y MAbs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Y MAbs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Y MAbs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Y MAbs alpha.

Y MAbs Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
What To Expect From Y-mAbs Therapeutics Inc Q3 2024 Earnings
11/07/2024
2
Y-mAbs Therapeutics, Inc. Given Consensus Rating of Moderate Buy by Brokerages - MarketBeat
11/21/2024
3
Y-mAbs to Participate at Citis 2024 Global Healthcare Conference
11/27/2024
4
Acquisition by Wg Biotech Aps of 30671 shares of Y MAbs at 5.8125 subject to Rule 16b-3
12/06/2024
5
Y-mAbs Therapeutics, Inc. Shares Sold by Point72 Asset Management L.P. - MarketBeat
12/11/2024
6
Were Hopeful That Y-mAbs Therapeutics Will Use Its Cash Wisely
12/20/2024
7
Insider Trading
01/06/2025
8
Correcting Replacing Y-mAbs Provides Strategic Business Update and 2025 Priorities
01/10/2025
9
Y-mAbs Therapeutics Updates on Business and Clinical Trials - TipRanks
01/13/2025

Complementary Tools for YMAB Stock analysis

When running Y MAbs' price analysis, check to measure Y MAbs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Y MAbs is operating at the current time. Most of Y MAbs' value examination focuses on studying past and present price action to predict the probability of Y MAbs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Y MAbs' price. Additionally, you may evaluate how the addition of Y MAbs to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Valuation
Check real value of public entities based on technical and fundamental data